Soleno Therapeutics (SLNO) Total Debt (2013 - 2026)
Soleno Therapeutics (SLNO) posted quarterly Total Debt of $49.9 million for Q1 2026, little changed year-over-year from $49.8 million in Q1 2025, and little changed quarter-over-quarter from $49.9 million in Q4 2025.
Soleno Therapeutics (SLNO) Total Debt (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has reported Total Debt for 5 consecutive years, with $49.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Debt changed 0.07% year-over-year to $49.9 million; the TTM figure through Mar 2026 stood at $49.9 million (changed 0.07% YoY), while the FY2025 annual figure was $49.9 million, changed 0.07% from the prior year.
- Total Debt was little changed at $49.9 million in Q1 2026 per SLNO's latest filing, from $49.9 million in the prior quarter.
- Across five years, Total Debt topped out at $49.9 million in Q1 2026 and bottomed at $49.8 million in Q4 2024.
- Historically, Total Debt has averaged $49.8 million across 3 years, with a median of $49.8 million in 2025.
- Annual changes were most pronounced in 2025 — Total Debt gained 0.07% — and 2026, when it climbed 0.07%.
- Soleno Therapeutics' Total Debt stood at $49.8 million in 2024, then advanced by 0.07% to $49.9 million in 2025, then climbed by 0.02% to $49.9 million in 2026.
- Business Quant data shows SLNO's Total Debt at $49.9 million in Q1 2026, $49.9 million in Q4 2025, and $49.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn | 49.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.87 Mn |
| Dec 31, 2025 | 49.86 Mn |
| Sep 30, 2025 | 49.85 Mn |
| Jun 30, 2025 | 49.85 Mn |
| Mar 31, 2025 | 49.84 Mn |
| Dec 31, 2024 | 49.83 Mn |
| Dec 31, 2014 | 101,529.00 |
| Dec 31, 2013 | 13.99 Mn |